25021-230 : Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution


NDC25021-230
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Irinotecan Hydrochloride
Dosage Form: Intravenous Injection, Solution
Application #: ANDA090675
Rev. Date: 


NDC Package Codes:

  • 25021-230-02: 1 VIAL IN 1 CARTON (25021‑230‑02) > 2 ML IN 1 VIAL
  • 25021-230-05: 1 VIAL IN 1 CARTON (25021‑230‑05) > 5 ML IN 1 VIAL

Active Ingredients:

  • Irinotecan Hydrochloride

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 25021-214 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 0143-9583 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9701 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0143-9702 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0703-4432 Irinotecan Hydrochloride 40 mg/2ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-4434 Irinotecan Hydrochloride 100 mg/5ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 16714-725 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Northstar Rxllc
  • 16714-726 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Northstar Rxllc
  • 23155-179 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc.
  • 45963-614 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution by Actavis Pharma, Inc.
  • 47335-937 Irinotecan Hydrochloride 40 mg/2ml Intravenous Injection by Sun Pharma Global Fze
  • 47335-953 Irinotecan Hydrochloride 100 mg/5ml Intravenous Injection by Sun Pharma Global Fze
  • 50742-401 Irinotecan Hydrochloride 40 mg/2ml Intravenous Injection by Ingenus Pharmaceuticals, LLC
  • 50742-402 Irinotecan Hydrochloride 100 mg/5ml Intravenous Injection by Ingenus Pharmaceuticals, LLC
  • 53104-0151 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Cipla Limited
  • 57884-3001 Irinotecan Hydrochloride 40 mg/2ml Intravenous Injection by Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • 57884-3002 Irinotecan Hydrochloride 100 mg/5ml Intravenous Injection by Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • 59923-702 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Areva Pharmaceuticals, Inc.
  • 59923-714 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Areva Pharmaceuticals, Inc.
  • 59923-715 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Areva Pharmaceuticals, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-230 QR Code

< Prev: 25021-222Next: 25021-231 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA